drugset / Trial / NCT00815308

Summary

The purpose of this study is to determine whether the treatment of locally advanced esophageal squamous cell carcinoma (ESCC)with cetuximab in combination with paclitaxel, cisplatin and radiation improve clinical outcomes.

Timeline

Start
2009-01
Primary completion
2010-07
Completion
2010-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cetuximab Monoclonal antibody 250 mg/m2 —
Subject Cisplatin Other / unclassified 20 mg/m2 —
Subject Paclitaxel Small molecule 45 mg/m2 —

Indications